BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34225733)

  • 21. Exploring the molecular mechanisms of osteosarcoma by the integrated analysis of mRNAs and miRNA microarrays.
    Shen H; Wang W; Ni B; Zou Q; Lu H; Wang Z
    Int J Mol Med; 2018 Jul; 42(1):21-30. PubMed ID: 29620143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of potential crucial genes and key pathways in osteosarcoma.
    Liu J; Wu S; Xie X; Wang Z; Lei Q
    Hereditas; 2020 Jul; 157(1):29. PubMed ID: 32665038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterizing biomarkers in osteosarcoma metastasis based on an ego-network.
    Liu Z; Song Y
    Biotechnol Lett; 2017 Jun; 39(6):841-848. PubMed ID: 28229297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of immune-related genes as prognostic biomarkers for the assessment of osteosarcoma clinical outcomes.
    Guo J; Li X; Shen S; Wu X
    Sci Rep; 2021 Dec; 11(1):24123. PubMed ID: 34916564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of N6-methylandenosine related LncRNAs biomarkers associated with the overall survival of osteosarcoma.
    Zhang P; Xu K; Wang J; Zhang J; Quan H
    BMC Cancer; 2021 Dec; 21(1):1285. PubMed ID: 34852770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulatory network of differentially expressed genes in metastatic osteosarcoma.
    Yao P; Wang ZB; Ding YY; Ma JM; Hong T; Pan SN; Zhang J
    Mol Med Rep; 2015 Mar; 11(3):2104-10. PubMed ID: 25434727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Differentially Expressed Genes (DEGs) Relevant to Prognosis of Ovarian Cancer by Use of Integrated Bioinformatics Analysis and Validation by Immunohistochemistry Assay.
    Zhang L; Sun L; Zhang B; Chen L
    Med Sci Monit; 2019 Dec; 25():9902-9912. PubMed ID: 31871312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma.
    Zhang X; Wen Z; Wang Q; Ren L; Zhao S
    Front Immunol; 2023; 14():1199869. PubMed ID: 37575253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
    Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
    BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysis.
    Zhu KP; Zhang CL; Shen GQ; Zhu ZS
    Int J Clin Exp Pathol; 2015; 8(8):8754-73. PubMed ID: 26464619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of SPI1-TYROBP-FCER1G network in oncogenesis and prognosis of osteosarcoma, and its association with immune infiltration.
    Li J; Shi H; Yuan Z; Wu Z; Li H; Liu Y; Lu M; Lu M
    BMC Cancer; 2022 Jan; 22(1):108. PubMed ID: 35078433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated Genome-Wide Methylation and Expression Analyses Reveal Key Regulators in Osteosarcoma.
    Wang F; Qin G; Liu J; Wang X; Ye B
    Comput Math Methods Med; 2020; 2020():7067649. PubMed ID: 32855654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative Transcriptome Analysis Quantifies Immune Cell Transcript Levels, Metastatic Progression, and Survival in Osteosarcoma.
    Scott MC; Temiz NA; Sarver AE; LaRue RS; Rathe SK; Varshney J; Wolf NK; Moriarity BS; O'Brien TD; Spector LG; Largaespada DA; Modiano JF; Subramanian S; Sarver AL
    Cancer Res; 2018 Jan; 78(2):326-337. PubMed ID: 29066513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospero homeobox 1 promotes proliferation, migration, and invasion of osteosarcoma cells and its clinical significance.
    Liu D; Wang R; Wang Y; Wang Y; Wang L
    Bioengineered; 2022 Feb; 13(2):2259-2271. PubMed ID: 35030967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 36. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma cancer.
    Liu R; Hu Y; Liu T; Wang Y
    BMC Cancer; 2021 Dec; 21(1):1345. PubMed ID: 34922489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of potential key genes associated with osteosarcoma based on integrated bioinformatics analyses.
    Hu G; Cheng Z; Wu Z; Wang H
    J Cell Biochem; 2019 Aug; 120(8):13554-13561. PubMed ID: 30920023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and functional analysis of differentially expressed genes related to metastatic osteosarcoma.
    Niu F; Zhao S; Xu CY; Chen L; Ye L; Bi GB; Tian G; Gong P; Nie TH
    Asian Pac J Cancer Prev; 2014; 15(24):10797-801. PubMed ID: 25605179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of potential micro-messenger RNAs (miRNA-mRNA) interaction network of osteosarcoma.
    Xu K; Zhang P; Zhang J; Quan H; Wang J; Liang Y
    Bioengineered; 2021 Dec; 12(1):3275-3293. PubMed ID: 34252359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Key genes with prognostic values in suppression of osteosarcoma metastasis using comprehensive analysis.
    Li M; Jin X; Li H; Wu G; Wang S; Yang C; Deng S
    BMC Cancer; 2020 Jan; 20(1):65. PubMed ID: 31992246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.